Showing results (41-50 of 439) with videos related to
Sort By:
Pageof 44
International Journal of Hematologic Oncology|October 11, 2018
Current first- and second-line treatment options in acute promyelocytic leukemiaFulvio Massaro, Matteo Molica, Massimo BrecciaLeukemia & Lymphoma|May 23, 2015
Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular responseRoberto Latagliata, Angela Romano, Marco Mancini, et al.Cancer Letters|November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?Massimo Breccia, Fabio Efficace, Giuliana AlimenaExpert Review of Molecular Diagnostics|September 21, 2017
Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an updateMatteo Molica, Fulvio Massaro, Massimo BrecciaCritical Reviews in Oncology/Hematology|January 28, 2012
Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety dataMassimo Breccia, Mario Tiribelli, Giuliana AlimenaLeukemia Research|December 3, 2014
How tyrosine kinase inhibitors impair metabolism and endocrine system function: a systematic updated reviewMassimo Breccia, Matteo Molica, Giuliana AlimenaMediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
Management of acute promyelocytic leukemia in the elderlyFrancesco Lo-Coco, Roberto Latagliata, Massimo BrecciaExpert Review of Anticancer Therapy|September 28, 2020
On the road to treatment-free remission in chronic myeloid leukemia: what about 'the others'?Fabio Stagno, Massimo Breccia, Francesco Di RaimondoBritish Journal of Haematology|December 22, 2015
Current standard treatment of adult acute promyelocytic leukaemiaFrancesco Lo-Coco, Laura Cicconi, Massimo BrecciaBest Practice & Research. Clinical Haematology|August 26, 2003
The importance of molecular monitoring in acute promyelocytic leukaemiaFrancesco Lo-Coco, Massimo Breccia, Daniela DiverioPageof 44